Accendra Financial Statements From 2010 to 2026

ACH Stock  USD 2.21  0.13  6.25%   
Accendra Health's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Accendra Health's valuation are provided below:
Market Capitalization
147.7 M
Earnings Share
(17.41)
We have found one hundred twenty available fundamental signals for Accendra Health, which can be analyzed and compared to other ratios and to its rivals. Traders should compare all of Accendra Health prevailing fundamentals against the fundamentals between 2010 and 2026 to make sure the company is sustainable this year. The Accendra Health's current Enterprise Value is estimated to increase to about 2 B, while Market Cap is projected to decrease to under 25.1 M.

Accendra Health Total Revenue

12.92 Billion

Check Accendra Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Accendra Health's main balance sheet or income statement drivers, such as Depreciation And Amortization of 319.7 M, Interest Expense of 173.6 M or Total Revenue of 12.9 B, as well as many indicators such as Price To Sales Ratio of 0.0058, Dividend Yield of 0.0049 or PTB Ratio of 0.0884. Accendra financial statements analysis is a perfect complement when working with Accendra Health Valuation or Volatility modules.
  
Build AI portfolio with Accendra Stock
Check out the analysis of Accendra Health Correlation against competitors.
For more detail on how to invest in Accendra Stock please use our How to Invest in Accendra Health guide.

Accendra Health Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets5.6 B5.4 B3.4 B
Slightly volatile
Short and Long Term Debt Total2.6 B2.5 B1.3 B
Slightly volatile
Other Current Liabilities696.2 M663.1 M373.4 M
Slightly volatile
Total Current Liabilities2.3 B2.2 B1.3 B
Slightly volatile
Total Stockholder Equity539 M650 M774.6 M
Very volatile
Property Plant And Equipment NetB994.7 M456.3 M
Slightly volatile
Net Debt2.5 B2.4 B1.2 B
Slightly volatile
Retained Earnings6.6 M6.9 M379.5 M
Slightly volatile
Cash54.1 M56.8 M95.7 M
Very volatile
Non Current Assets Total3.2 BB1.5 B
Slightly volatile
Non Currrent Assets Other161.9 M154.2 M91.2 M
Slightly volatile
Cash And Short Term Investments54.1 M56.8 M95.7 M
Very volatile
Net Receivables435.8 M793.8 M616.2 M
Slightly volatile
Common Stock Shares Outstanding2.4 M3.5 M2.6 M
Slightly volatile
Liabilities And Stockholders Equity5.6 B5.4 B3.4 B
Slightly volatile
Non Current Liabilities Total2.7 B2.5 B1.3 B
Slightly volatile
Inventory1.4 B1.3 BB
Slightly volatile
Other Current Assets105.3 M171.9 M203.1 M
Very volatile
Other Stockholder Equity548.4 M522.3 M305.3 M
Slightly volatile
Total Liabilities4.9 B4.7 B2.7 B
Slightly volatile
Total Current Assets1.2 B2.3 B1.9 B
Slightly volatile
Short Term Debt38.2 M52 M49.5 M
Slightly volatile
Intangible Assets358.3 M341.2 M209.5 M
Slightly volatile
Accounts Payable1.5 B1.4 B903.1 M
Slightly volatile
Common Stock118.6 M177.6 M132.1 M
Slightly volatile
Good Will1.6 B1.5 B726.5 M
Slightly volatile
Long Term DebtB2.1 B1.3 B
Slightly volatile
Capital Lease Obligations247.7 M345.8 M192.9 M
Slightly volatile
Net Invested CapitalB2.8 B2.2 B
Slightly volatile
Property Plant And Equipment Gross1.4 B1.6 BB
Slightly volatile
Capital Stock168 M177.6 M153.9 M
Slightly volatile
Non Current Liabilities Other89.3 M90.1 M107.3 M
Slightly volatile
Net Working Capital125.9 M132.6 M769.3 M
Slightly volatile
Other Assets1.7 M1.8 M124.1 M
Slightly volatile
Long Term Debt Total1.6 B1.6 B2.3 B
Slightly volatile
Capital Surpluse479.3 M522.3 M431.5 M
Slightly volatile
Short and Long Term Debt43.7 M46 M33.5 M
Slightly volatile
Cash And Equivalents42.2 M44.4 M75.4 M
Very volatile
Property Plant Equipment940.3 M994.7 M871 M
Slightly volatile

Accendra Health Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization319.7 M304.5 M124.3 M
Slightly volatile
Interest Expense173.6 M165.4 M71.6 M
Slightly volatile
Total Revenue12.9 B12.3 B9.3 B
Slightly volatile
Gross Profit2.7 B2.6 B1.4 B
Slightly volatile
Other Operating Expenses13.2 B12.5 B9.2 B
Slightly volatile
Cost Of Revenue5.3 B9.8 B7.6 B
Slightly volatile
Total Operating Expenses2.9 B2.8 B1.4 B
Slightly volatile
Selling General Administrative2.3 B2.2 B1.1 B
Slightly volatile
Selling And Marketing Expenses15.3 K16.1 K337.3 M
Slightly volatile
Reconciled Depreciation239.6 M304.5 M141.9 M
Slightly volatile
Interest Income157.9 M165.4 M135.3 M
Slightly volatile

Accendra Health Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation319.7 M304.5 M128.1 M
Slightly volatile
End Period Cash Flow64.7 M56.8 M109.2 M
Very volatile
Begin Period Cash Flow329.6 M313.9 M146.4 M
Slightly volatile
Stock Based Compensation32.4 M30.9 M16.5 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio0.00580.00340.0067
Slightly volatile
Dividend Yield0.00490.00520.5524
Slightly volatile
PTB Ratio0.08840.08160.0754
Very volatile
Days Sales Outstanding32.8727.0826.9535
Very volatile
Book Value Per Share168166292
Slightly volatile
Stock Based Compensation To Revenue0.00120.00230.0015
Slightly volatile
Capex To Depreciation1.070.990.8341
Slightly volatile
PB Ratio0.08840.08160.0754
Very volatile
EV To Sales0.190.180.1218
Slightly volatile
Inventory Turnover9.618.628.1544
Slightly volatile
Days Of Inventory On Hand34.5143.8446.4116
Slightly volatile
Payables Turnover11.817.799.8922
Slightly volatile
Sales General And Administrative To Revenue0.170.160.1133
Slightly volatile
Capex To Revenue0.02010.01920.0096
Slightly volatile
Cash Per Share15.5414.4836.1046
Pretty Stable
Days Payables Outstanding28.6148.4939.1767
Slightly volatile
Intangibles To Total Assets0.330.310.2254
Slightly volatile
Current Ratio2.091.241.7196
Slightly volatile
Receivables Turnover10.3913.9513.9538
Very volatile
Shareholders Equity Per Share163166291
Slightly volatile
Debt To Equity3.583.411.7792
Slightly volatile
Capex Per Share70.2466.932.9288
Slightly volatile
Revenue Per Share1.8 K3.1 K3.3 K
Very volatile
Interest Debt Per Share703670454
Slightly volatile
Debt To Assets0.430.410.3172
Slightly volatile
Graham Number9.978.3416.2359
Slightly volatile
Short Term Coverage Ratios3.823.6312.53
Slightly volatile
Operating Cycle80.3283.0974.8422
Slightly volatile
Price Book Value Ratio0.08840.08160.0754
Very volatile
Days Of Payables Outstanding28.6148.4939.1767
Slightly volatile
Company Equity Multiplier7.787.414.6655
Slightly volatile
Long Term Debt To Capitalization0.340.690.4911
Slightly volatile
Total Debt To Capitalization0.750.710.5313
Slightly volatile
Debt Equity Ratio3.583.411.7792
Slightly volatile
Quick Ratio1.030.550.8472
Slightly volatile
Net Income Per E B T0.570.910.8782
Slightly volatile
Cash Ratio0.02250.02370.0828
Slightly volatile
Cash Conversion Cycle20.0821.1335.2192
Slightly volatile
Days Of Inventory Outstanding34.5143.8446.4116
Slightly volatile
Days Of Sales Outstanding32.8727.0826.9535
Very volatile
Price To Book Ratio0.08840.08160.0754
Very volatile
Fixed Asset Turnover13.5214.2333.1728
Slightly volatile
Debt Ratio0.430.410.3172
Slightly volatile
Price Sales Ratio0.00580.00340.0067
Slightly volatile
Asset Turnover3.982.643.0941
Slightly volatile
Gross Profit Margin0.0960.190.1392
Slightly volatile
Price Fair Value0.08840.08160.0754
Very volatile

Accendra Health Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap25.1 M36.1 M53.3 M
Slightly volatile
Enterprise ValueB1.9 B1.4 B
Slightly volatile

Accendra Fundamental Market Drivers

About Accendra Health Financial Statements

Investors use fundamental indicators, such as Accendra Health's revenue or net income, to determine how well the company is positioned to perform in the future. Although Accendra Health's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Current Deferred Revenue133.9 M140.6 M
Total Revenue12.3 B12.9 B
Cost Of Revenue9.8 B5.3 B
Sales General And Administrative To Revenue 0.16  0.17 
Capex To Revenue 0.02  0.02 
Revenue Per Share3.1 K1.8 K
Ebit Per Revenue(0.02)(0.02)

Currently Active Assets on Macroaxis

When determining whether Accendra Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Accendra Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Accendra Health Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Accendra Health Stock:
Check out the analysis of Accendra Health Correlation against competitors.
For more detail on how to invest in Accendra Stock please use our How to Invest in Accendra Health guide.
You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Is there potential for Medical Distribution market expansion? Will Accendra introduce new products? Factors like these will boost the valuation of Accendra Health. If investors know Accendra will grow in the future, the company's valuation will be higher. Understanding fair value requires weighing current performance against future potential. All the valuation information about Accendra Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(17.41)
Return On Equity
(184.47)
Understanding Accendra Health requires distinguishing between market price and book value, where the latter reflects Accendra's accounting equity. The concept of intrinsic value—what Accendra Health's is actually worth based on fundamentals—guides informed investors toward better entry and exit points. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Market sentiment, economic cycles, and investor behavior can push Accendra Health's price substantially above or below its fundamental value.
Understanding that Accendra Health's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Accendra Health represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, Accendra Health's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.